TE_38265

Basic information Differential Expression Stage analysis Survival analysis Correlation analysis

TE family LTR7C
TE superfamily ERV1
TE class LTR
Gene PLCXD1
Class Chimeric
Coding Non-coding, Other
Tumor-specific score 213.02
Counts of samples TCGA_tumor:188; TCGA_normal:0; GTEx:0
TSS chrX(+):279097



Transcript isoforms

Transcript_ID Gene Class Coding ORF Position
teRNA_38265.1 PLCXD1 Chimeric Non-coding Non-coding chrX(+):279098,279185,284167,284314,288733,288869,290648,290776,291499,291654,293035,293218,299097,299117
teRNA_38265.2 PLCXD1 Chimeric Other MGGQVSASNSFSRLHCRNANEDWMSALCPRLWDVPLHHLSIPGSHDTMTYCLNKKSPISHEESRLLQLLNKALPCITRPVVLKWSVTQALDVTEQLDAGVRYLDLRIAHMLEGSEKNLHFVHMVYTTALVEVRPG* chrX(+):279098,279185,284167,284314,288733,288869,290648,290792,291499,291519
teRNA_38265.3 PLCXD1 Chimeric Non-coding Non-coding chrX(+):279098,279185,284167,284314,288733,288869,290648,290776,291499,291519
teRNA_38265.4 PLCXD1 Chimeric Non-coding Non-coding chrX(+):279098,279185,284167,284314,288733,288753
teRNA_38265.5 PLCXD1 Chimeric Non-coding Non-coding chrX(+):279098,279185,281482,281684,284167,284314,288733,288869,290648,290776,291499,291654,293035,293218,299097,299117
teRNA_38265.6 PLCXD1 Chimeric Non-coding Non-coding chrX(+):279098,279185,281482,281684,284167,284314,288733,288753
teRNA_38265.7 PLCXD1 Chimeric Non-coding Non-coding chrX(+):279098,279185,279293,279439,281482,281684,284167,284314,288733,288869,290648,290776,291499,291654,293035,293218,299097,299117
teRNA_38265.8 PLCXD1 Chimeric Non-coding Non-coding chrX(+):279098,279185,279293,279439,281482,281684,284167,284314,288733,288753
teRNA_38265.9 PLCXD1 Chimeric Non-coding Non-coding chrX(+):279098,279185,281610,281684,284167,284314,288733,288869,290648,290776,291499,291654,293035,293218,299097,299117
teRNA_38265.10 PLCXD1 Chimeric Non-coding Non-coding chrX(+):279098,279185,281610,281684,284167,284314,288733,288753


GTEx

The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.




TCGA

The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).




GTEx

The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.




TCGA

The expression of TE-initiated transcript across 33 cancer types from The Cancer Genome Atlas (TCGA).